Results 61 to 70 of about 8,542,002 (198)

Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients

Seminars in Dialysis, Volume 39, Issue 3, Page 105-115, May/June 2026.
ABSTRACT Microinflammation and functional iron deficiency are major contributors to anemia and treatment burden in maintenance hemodialysis (HD). Medium cutoff (MCO) membranes enhance the removal of middle‐ and large‐sized solutes implicated in these pathways, yet real‐world data using routinely measured inflammatory and iron‐related markers are scarce.
Berrak Itır Aylı, Gülay Ulusal Okyay, Mehmet Deniz Aylı   +2 more
wiley   +1 more source

Comparison of Fracture Risk among End-Stage Renal Disease Patients on Online Hemodiafiltration versus High flux Hemodialysis [PDF]

Arcades of Medicine
Background: Chronic kidney disease mineral and bone disorder contributes significantly to morbidity, mortality, and fracture risk (FRAX) in end-stage renal disease (ESRD) patients.
Hany Lotfy, Khaled Abdelwahab, Maha Said, Hamdy Ali   +3 more
doaj   +1 more source

Particulates formed in dialysis fluid: effect of silica in tap water

Renal Replacement Therapy, 2022
Background A fluid commonly used for dialysis in Japan is prepared from two dialysate concentrates and dialysis water. Silicon (Si) from tap water is reported in dialysis water as suspended insoluble particulate matters. We aimed to examine the source of
Motoyuki Imai, Masahito Yamamoto, Konomi Togo, Akihiro C. Yamashita   +3 more
doaj   +1 more source

Success in Achieving Relatively High Targeted Convection Volumes in Multi‐Ethnic Individuals Receiving Hemodiafiltration in Singapore

Hemodialysis International, Volume 30, Issue 2, Page 305-312, April 2026.
ABSTRACT Background Hemodiafiltration has demonstrated improved outcomes in end‐stage kidney disease, particularly with higher convection volumes than conventional hemodialysis. However, data on multiethnic Asian populations remain limited.
Cindy Chan, Sugandha Saxena, Yan Yi Cheung, Nandakumar Mooppil, Akira Wu, Luca Neri, Jeffrey L. Hymes, Franklin W. Maddux, Benjamin E. Hippen, Milind Nikam   +9 more
wiley   +1 more source

Successful Management of Suspected Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in BRAF‐Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report

Cancer Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background The BRAF V600E mutation is a rare genetic alteration in cholangiocarcinoma for which sequential therapy with immune checkpoint inhibitors (ICIs) and BRAF/MEK inhibitors may be effective. However, the full spectrum of adverse events associated with the sequential use of these agents remains unclear. Hemophagocytic lymphohistiocytosis
Akira Shibata, Michihiro Ono, Shutaro Oiwa, Atsushi Uesugi, Seiya Saito, Makoto Usami, Tomoyuki Abe, Masahiro Yoshida, Masahiro Maeda, Kohichi Takada   +9 more
wiley   +1 more source

Genetic damage in patients moving from hemodialysis to online hemodiafiltration [PDF]

Mutagenesis, 2015
End-stage renal failure patients exhibit a high incidence of genetic damage and genomic instability. Part of this genetic damage is assumed to be caused by the hemodialysis (HD) procedure. To reduce these effects, different alternative HD procedures have been proposed, such as the use of high efficiency convective therapies to improve the reactive ...
Lara, Rodríguez-Ribera, Susana, Pastor, Zuray, Corredor, Irene, Silva, Juan Manuel, Diaz, José, Ballarin, Ricardo, Marcos, Elisabeth, Coll   +7 more
openaire   +2 more sources

Liver Transplant Anesthesia Practice Patterns in Canada, Australia, and New Zealand: Results From a Multi‐National Survey

Clinical Transplantation, Volume 40, Issue 1, January 2026.
Abstract Background Liver transplantation is the only curative treatment for end‐stage liver disease, yet perioperative management is complex and high‐risk. Variations in anesthetic practices may influence outcomes, but benchmarks are scant. This study characterizes liver transplant anesthesia practices in Canada, Australia, and New Zealand to identify
Elizabeth van Rooy, Daniel Sellers, Stuart McCluskey, Cara Crouch   +3 more
wiley   +1 more source

Are medium cut-off membranes the future, or the promising reality for chronic hemodialysis patients?

Revista de Investigación Clínica, 2023
The development of hemodialysis (HD) membranes has substantially advanced in the last decade. This has resulted in the manufacturing of medium cut-off membranes (MCO) whose internal architecture is based on greater pore size and a smaller diameter, thus ...
Noemí Del Toro-Cisneros, Erick Y. Zuñiga-González, Adrián E. Caballero-Islas, José A. Geraldo-Murillo, Mauricio Arvizu-Hernández, Olynka Vega-Vega   +5 more
doaj   +1 more source

Use of Extracorporeal Therapies to Treat Severe Caffeine Poisoning

Hemodialysis International, Volume 30, Issue 1, Page 73-79, January 2026.
ABSTRACT Introduction Reflecting on recent reports suggesting the efficacy of extracorporeal blood purification, including hemodialysis, for severe caffeine poisoning, we conducted a retrospective 5‐year follow‐up study on acute caffeine poisoning in Japan particularly focusing on extracorporeal blood purification.
Saeko Kohara, Yoshito Kamijo, Michiko Takai, Ryoko Kyan, Eiju Hasegawa, Takuya Shimane   +5 more
wiley   +1 more source

Advancing high-volume hemodiafiltration: from concept to CONVINCE

Nefrología Latinoamericana
Conventional kidney replacement therapy (KRT) for end-stage kidney disease (ESKD) is associated with unmet medical needs, limited efficiency, poor patient outcomes, perception, and high costs. Advancements, including synthetic high-flux membranes, better-
Bernard Canaud
doaj   +1 more source